Viewing Study NCT01998893


Ignite Creation Date: 2025-12-25 @ 1:20 AM
Ignite Modification Date: 2026-04-15 @ 2:28 AM
Study NCT ID: NCT01998893
Status: COMPLETED
Last Update Posted: 2014-12-03
First Post: 2013-11-25
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of MabThera/Rituxan (Rituximab) in Patients With Relapsed Centroblastic Centrocytic Non-Hodgkin's Lymphoma
Sponsor: Hoffmann-La Roche
Organization: